Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Difference Capital Financial was a Toronto-based publicly listed specialty finance and investment company, not a biotech or healthcare operating company. It provided debt and equity growth capital and advisory services to later-stage growth businesses, with investments spanning technology, media, fintech, and some healthcare-related companies. The company appears to have functioned primarily as an investor rather than as a developer of therapeutics, diagnostics, or medical products. In 2019, Difference Capital completed a business combination with Mogo, after which Difference changed its name to Mogo Inc. and ceased operating as an independent company. As a result, it does not have a therapeutic pipeline, clinical programs, or platform technology in the biotech sense.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Difference Capital Financial.